The therapeutic potential of the use of gliclazide MV in combination with COVID-19 and type 2 diabetes mellitus | Belikina | FOCUS. Endocrinology

FOCUS. Endocrinology
Focus. Èndokrinologiâ

ISSN 2713-0177 (Print)
ISSN 2713-0185 (Online)

eng | рус

Preview

FOCUS. Endocrinology

Advanced search

Archives

Download this PDF file

For citations:

Belikina D.V., Nekrasova T.A., Strongin L.G., Durygina E.M., Rodina M.Yu. The therapeutic potential of the use of gliclazide MV in combination with COVID-19 and type 2 diabetes mellitus. FOCUS. Endocrinology. 2024;5(1):20-23. (In Russ.) https://doi.org/10.62751/2713-0177-2024-5-1-03

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 2713-0177 (Print)
ISSN 2713-0185 (Online)

* not an advertisement

Indexing Databases

* not an advertisement

Popular articles

Editor-in-Chief

Tatiana Yu. Demidova

Article Tools

Finding References

Email this article (Login required)

Email the author (Login required)

About the Authors

D. V. Belikina
Privolzhsky Research Medical University
Russian Federation

Darya V. Belikina– Assistant of the Department of Endocrinology and Internal Diseases

Nizhny Novgorod

T. A. Nekrasova
Privolzhsky Research Medical University
Russian Federation

Tatyana A. Nekrasova– Doc. Sci. (Med.), Associate Professor, Professor of the Department of Endocrinology and Internal Diseases

Nizhny Novgorod

L. G. Strongin
Privolzhsky Research Medical University
Russian Federation

Leonid G. Strongin – Doc. Sci. (Med.), Professor; Professor of the Department of Endocrinology and Internal Medicine

Nizhny Novgorod

E. M. Durygina
Privolzhsky Research Medical University
Russian Federation

Elena M. Durygina – Can. Sci. (Med.), Associate Professor of the Department of Internal Medicine and Cardiology

Nizhny Novgorod

M. Yu. Rodina
Privolzhsky Research Medical University
Russian Federation

Marina Yu. Rodina – Assistant of the Department of Faculty and Outpatient Therapy

Nizhny Novgorod

Notifications